-
Loading metrics
Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients
- Anita K. Gandhi,
- Tao Shi,
- Mingyu Li,
- Ulf Jungnelius,
- Alfredo Romano,
- Josep Tabernero,
- Salvatore Siena,
- Peter H. Schafer,
- Rajesh Chopra
x
- Published: November 11, 2013
- https://doi.org/10.1371/journal.pone.0080437
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved